| Literature DB >> 30962283 |
Mei-Kuang Chen1,2, Yi Du2, Linlin Sun2,3, Jennifer L Hsu2, Yu-Han Wang2,4, Yuan Gao2,5, Jiaxing Huang2,6, Mien-Chie Hung7,2,4,8.
Abstract
Reactive oxygen species (ROS) are cellular by-products produced from metabolism and also anticancer agents, such as ionizing irradiation and chemotherapy drugs. The ROS H2O2 has high rates of production in cancer cells because of their rapid proliferation. ROS oxidize DNA, protein, and lipids, causing oxidative stress in cancer cells and making them vulnerable to other stresses. Therefore, cancer cell survival relies on maintaining ROS-induced stress at tolerable levels. Hepatocyte growth factor receptor (c-MET) is a receptor tyrosine kinase overexpressed in malignant cancer types, including breast cancer. Full-length c-MET triggers a signal transduction cascade from the plasma membrane that, through downstream signaling proteins, up-regulates cell proliferation and migration. Recently, c-MET was shown to interact and phosphorylate poly(ADP-ribose) polymerase 1 in the nucleus and to induce poly(ADP-ribose) polymerase inhibitor resistance. However, it remains unclear how c-MET moves from the cell membrane to the nucleus. Here, we demonstrate that H2O2 induces retrograde transport of membrane-associated full-length c-MET into the nucleus of human MCF10A and MCF12A or primary breast cancer cells. We further show that knocking down either coatomer protein complex subunit γ1 (COPG1) or Sec61 translocon β subunit (SEC61β) attenuates the accumulation of full-length nuclear c-MET. However, a c-MET kinase inhibitor did not block nuclear c-MET transport. Moreover, nuclear c-MET interacted with KU proteins in breast cancer cells, suggesting a role of full-length nuclear c-MET in ROS-induced DNA damage repair. We conclude that a membrane-bound retrograde vesicle transport mechanism facilitates membrane-to-nucleus transport of c-MET in breast cancer cells.Entities:
Keywords: breast cancer; c-MET; hepatocyte growth factor receptor (HGFR); hydrogen peroxide; nuclear transport; nucleus; reactive oxygen species (ROS); receptor tyrosine kinase; vesicle trafficking
Mesh:
Substances:
Year: 2019 PMID: 30962283 PMCID: PMC6544865 DOI: 10.1074/jbc.RA118.005953
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157